4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-21-000006
President and CEO sold 24,132 shares at an average $110.03 ($2,655,177)
- President and CEO acquired 24,132 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kramer Robert · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-20 | Exercise or conversion : show line 1 in the form | +2,232 | $26.45 | $59,036 | 141,442 | D |
| 2021-01-20 | Sale : show line 2 in the form | −2,232 | $110.00 | $245,520 | 139,210 | D |
| 2021-01-21 | Exercise or conversion : show line 3 in the form | +21,900 | $26.45 | $579,255 | 161,110 | D |
| 2021-01-21 | Sale : show line 4 in the form | −21,900 | $110.03 | $2,409,657 | 139,210 | D |
| Open-market sales · 24,132 sh · avg $110.03 · $2,655,177 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-20 | Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) | −2,232 | $110.00 | $245,520 | 21,900 | D |
| 2021-01-21 | Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) | −21,900 | $110.03 | $2,409,657 | 0 | D |
Loading xslF345X03/wf-form4_161135005224162.xml…